PSI Webinar: How can PSI, “a community dedicated to leading and promoting the use of statistics within the healthcare industries for the benefit of patients”, help you be more successful in your career?

PSI Training Course: Introduction to Machine Learning

This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.

Joint PSI/EFSPI Vaccine SIG Webinar: Statistical and Mechanistic Models for Correlates of Protection

This webinar will explore two different approaches to Correlates of Protection in vaccine development.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Webinar: Drug Development in Women's Health

The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.

PSI Webinar: Surrogacy

This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.

Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies

Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.

Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium

We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.

PSI Career Young Virtual Event (Q2 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q3 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Introduction to Industry Training (ITIT) Course - 2024/2025

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

PSI Career Young Virtual Event (Q4 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Speaker	Bio
Chrissie Fletcher GSK	Chrissie has recently joined GSK as Vice President, Development Biostatistics. Prior to GSK, Chrissie worked at Amgen for 22+ years where she was the Biostatistics Therapeutic Area Head for Cardiovascular, Metabolic, Neuroscience, Nephrology and Inflammation. Chrissie has worked in the Pharmaceutical Industry for 29 years and she has experience of developing and commercialising new medicines in a variety of therapeutic areas across all phases of clinical development. Chrissie is actively engaged in Statistical societies (e.g. PSI, EFSPI), Pharmaceutical trade associations (e.g. EFPIA) and initiatives relating to the Pharmaceutical Industry (e.g. ICH, IMI). In 2019 Chrissie was awarded PSI Honorary Member for her outstanding services to PSI, and she was an awardee of the Women in Data 2019 ‘Twenty Women in Data & Technology’ where she was recognised as an outstanding Women Leader.
Nigel Howitt Covance	Nigel is the Global Head and Executive Director of Biostatistics at Covance, covering Phases I to IV. He leads a department of >100 Biostatisticians from North America, EU, India and China. Nigel has 27 years of industry experience; 26 years at CROs (parexel, PRA Health Sciences and Covance). He was the Global Head of Biostatistics at PRA between 2009 to 2016 prior to joining Covance. Nigel has been an active member of professional organizations for many years. He has served twice on the PSI Board and on the Scientific Committee. He was the PSI Chair between July 2017 and July 2019, and is currently the Vice-Chair and Secretary. Nigel also served on the EFSPI Council and was the EFSPI President between 2007 and 2010. Nigel has a Postgraduate Diploma in Mathematical Statistics from Cambridge University (UK) and a BSc (hons) in Mathematics and Statistics from Bradford University (UK). Outside of work Nigel loves rugby, football, music and visiting the West End.

Event